BPI supports the objectives of the EU Strategy to advance medical countermeasures (MCMs) against public health threats. The Strategy aims to build a cohesive and coordinated European response framework that strengthens preparedness and emergency responsiveness. In an increasingly complex geopolitical landscape, it is crucial to accelerate the development and accessibility of crisis-relevant MCMs to boost the EU’s strategic autonomy. Given the global nature of many health threats, EU efforts should be coordinated with international partners to ensure aligned development, manufacturing and equitable access to MCMs worldwide – including capacity building in low- and middle-income countries.
